Login to Your Account



Mosaic merger brings Northern Biologics back to LIF(E)

By Cormac Sheridan
Staff Writer

Monday, December 19, 2016

DUBLIN – Northern Biologics Inc. is merging with Spanish firm Mosaic Biomedicals SL and at the same time has lined up Celgene Corp. with an option to take forward Mosaic's key asset, MSC-1, a first-in-class antibody that targets leukemia inhibitory factor.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription